Purple rice paste as well as preparation method and application thereof

By extracting rice extract from purple rice through a graded milling process, the problem of immature rice extract processing technology has been solved. This process produces purple rice extract containing a variety of active ingredients, which can be used to prepare biological agents that lower blood sugar, lower blood lipids, and promote intestinal peristalsis, thereby enhancing the economic value of rice.

CN119033064APending Publication Date: 2024-11-29HUNAN ZHUNONG RICE IND CO LTD +1
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202411259003.7
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-09-09
Publication Date
2024-11-29

AI Technical Summary

Technical Problem

In the existing technology, the processing technology of rice pearls is not mature, resulting in low product quality and affecting its nutritional components. Furthermore, there is a lack of research on the preparation process and nutritional value of purple rice pearls, which reduces the economic value of rice.

Method used

The process involves five milling steps, using rice milling machines with different currents, and finally passing the rice through a sieve with a suitable mesh size to obtain rice extracts from purple rice containing a variety of active ingredients.

Benefits of technology

The prepared purple rice extract can be used to prepare biological agents, effectively lowering blood sugar and blood lipids, promoting intestinal peristalsis, and improving the utilization value of purple rice resources.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure BDA0005034964880000041
    Figure BDA0005034964880000041
  • Figure BDA0005034964880000051
    Figure BDA0005034964880000051
  • Figure BDA0005034964880000052
    Figure BDA0005034964880000052
Patent Text Reader

Abstract

The invention relates to purple rice powder as well as a preparation method and application thereof. The purple rice powder is prepared by the following method: (1) first grinding: grinding out rice husks; (2) secondary rolling: rolling out peels; (3) third grinding: grinding out seed coats; (4) fourth grinding: grinding out an aleurone layer of which the concentration is not more than 25%; and (5) fifth grinding: grinding out the residual aleurone layer, collecting the ground-out material, and sieving with a 30-45-mesh sieve to obtain the aleurone powder. The purple rice treasure is prepared by performing graded milling and then sieving a milled material obtained by a fifth mill through a proper mesh sieve, contains a plurality of active substances, can effectively reduce blood sugar and blood fat, promote intestinal peristalsis and relax bowel, can be used for preparing biological agents for reducing blood sugar, reducing blood fat and promoting intestinal peristalsis, including medicines, foods, health-care products and the like, and has a wide application prospect. The utilization value of purple rice resources is greatly improved.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention belongs to the technical field of rice pearl production, and specifically relates to purple rice pearl and a preparation method and application thereof. Background Art

[0002] Japonica rice (Oryza sotiva L.subsp. joponica Kato) is a variety of rice. Japonica rice requires a short sunshine time, but has a long growth period, is relatively cold-resistant, has strong stickiness, short and round rice grains, high protein content, and good taste. The rice milled from japonica rice is called "japonica rice". Zhongzi No. 4 purple rice is a type of japonica rice, and is named because the rice grains milled are slender and purple. Compared with ordinary rice, the thickness of the aleurone layer of purple rice is 2-3 times that of ordinary indica rice. Therefore, purple rice not only has a very high protein content and a complete set of essential amino acids, but also contains a large amount of natural black rice pigment, a variety of trace elements and vitamins, especially rich in iron, selenium, zinc, vitamin B1, vitamin B2, etc.

[0003] Rice is the main processed product of paddy. Excessive processing and washing make the nutrition of rice less than 30% of that of paddy. Rice bran, which accounts for 6% to 8% of the total weight of paddy, is a byproduct of rice processing, but its nutritional content accounts for 64% of paddy. Traditional rice bran consists of a protective cortex and rice treasures, and contains a variety of bioactive substances, such as phenolic compounds (tocotrienols, tocopherols, etc.), phytosterols, oryzanol, etc. In addition, rice bran contains more than 90% of the essential elements for the human body and is a "natural nutrient treasure house". Despite this, due to insufficient research on its specific components, rice bran has always been only a low-value-added product of rice and is mostly used in the feed industry. At present, most studies only take rice bran as the object, and study the protective cortex and rice treasures as a whole, while there is less research on rice treasures with high nutritional content.

[0004] Rice jelly accounts for 5% to 9% of the total weight of rice grains. It is a natural nutrient made from the endosperm and embryo of rice. Due to the limitations of rice milling technology, the processing technology of rice jelly is immature, the product quality is low, and different processing technologies will also affect the nutritional content of rice jelly products. Therefore, rice jelly has always been regarded as a cheap by-product of rice processing, which greatly reduces the economic value of rice.

[0005] In addition, there are differences in the preparation process and nutritional value of rice treasures from different types of rice. Currently, there is a lack of research on the preparation process and efficacy of purple rice treasures. Summary of the invention

[0006] Based on this, the purpose of the present invention is to provide a purple rice treasure, which contains multiple active ingredients and can effectively lower blood sugar and blood lipids, promote intestinal peristalsis, and moisturize the intestines and promote bowel movements.

[0007] The first aspect of the present invention provides a method for preparing purple rice pearls, which uses a rice mill to extract purple rice pearls from purple rice, comprising the following steps:

[0008] (1) First grinding: grinding out the rice husks;

[0009] (2) Second grinding: grinding out the peel;

[0010] (3) Third grinding: grinding out the seed coat;

[0011] (4) Fourth grinding: grinding out no more than 25% of the aleurone layer;

[0012] (5) Fifth grinding: Grind out the remaining aleurone layer, collect the ground material, and pass it through a 30-45 mesh sieve to obtain the final product.

[0013] In some embodiments, the milled material is collected and passed through a 40-45 mesh sieve; preferably, the milled material is collected and passed through a 45 mesh sieve.

[0014] In some embodiments, the rice mill uses 40#-60# sand rollers;

[0015] Preferably, the rice mill uses a 60# sand roller; the current of the first mill is 10.7±0.2A; and / or the current of the second mill is 10.3±0.2A; and / or the current of the third mill is 10.2±0.2A; and / or the current of the fourth mill is 10.1±0.2A; and / or the current of the fifth mill is 10.1±0.2A.

[0016] In some embodiments, the purple rice is Zhongzi No. 4.

[0017] The second aspect of the present invention provides purple rice treasures prepared by the preparation method described above.

[0018] The third aspect of the present invention provides the use of the purple rice extract as described above in the preparation of a lipid-lowering biological agent.

[0019] The fourth aspect of the present invention provides the use of the purple rice extract as described above in the preparation of a biological agent for promoting intestinal peristalsis.

[0020] The fifth aspect of the present invention provides the use of the purple rice extract as described above in the preparation of a hypoglycemic biological agent.

[0021] In some embodiments, the biological agent is a drug, a health product or a food.

[0022] The sixth aspect of the present invention provides a biological preparation for lowering blood sugar, lowering blood lipids or promoting intestinal motility, comprising an active ingredient and an excipient, wherein the active ingredient includes the purple rice treasure as described above; the excipient is a pharmaceutically acceptable carrier, a health product acceptable carrier or a food acceptable carrier.

[0023] The invention provides a purple rice treasure, which is prepared by graded grinding and then passing the fifth grinding product containing most of the aleurone layer through a suitable mesh sieve, wherein the purple rice treasure contains a variety of active substances, can effectively reduce blood sugar and blood lipids, promote intestinal peristalsis, and moisturize the intestines and relieve constipation. Therefore, the purple rice treasure of the invention can be used to prepare biological preparations for reducing blood sugar, reducing blood lipids and promoting intestinal peristalsis, including medicines, foods and health products, etc., which greatly improves the utilization value of purple rice resources. BRIEF DESCRIPTION OF THE DRAWINGS

[0024] Figure 1 This is the result of measuring the α-amylase inhibition rate of the purple rice treasure of the present invention.

[0025] Figure 2 The results are as follows: The results are as follows: The results are as follows: The results are as follows:

[0026] Figure 3 This is the result of glucose level detection in zebrafish after being treated with purple rice extract of the present invention.

[0027] Figure 4 This is a typical image of triglyceride staining intensity in zebrafish tail blood vessels after treatment with the purple rice extract of the present invention. The yellow dotted line box in the image is the zebrafish analysis area.

[0028] Figure 5 It is the triglyceride staining intensity of the zebrafish tail blood vessels after being treated with the purple rice treasure of the present invention.

[0029] Figure 6 This is a typical graph of the cholesterol fluorescence intensity in the blood vessels of the tail of zebrafish after treatment with the purple rice extract of the present invention. The yellow dotted line frame in the graph is the zebrafish analysis area.

[0030] Figure 7 It is the cholesterol fluorescence intensity of the blood vessels in the tail of zebrafish after being treated with the purple rice treasure of the present invention.

[0031] Figure 8 This is a typical graph of the fluorescence intensity of the zebrafish intestine after being treated with the purple rice treasure of the present invention. The yellow dotted area in the figure is the analysis site of the zebrafish intestine.

[0032] Fig. 9 It is the fluorescence intensity of zebrafish intestine after being treated with purple rice treasure of the present invention.

[0033] Fig.10 This is a diagram of the structure of purple rice. DETAILED DESCRIPTION

[0034] In order to facilitate the understanding of the present invention, the present invention will be described more fully below. The present invention can be implemented in many different forms and is not limited to the embodiments described herein. On the contrary, the purpose of providing these embodiments is to make the understanding of the disclosure of the present invention more thorough and comprehensive.

[0035] The experimental methods in the following examples without specifying specific conditions are usually carried out under conventional conditions or conditions recommended by the manufacturers. The various commonly used chemical reagents used in the examples are all commercially available products.

[0036] Unless otherwise defined, all technical and scientific terms used in the present invention have the same meaning as those commonly understood by those skilled in the art to which the present invention belongs. The terms used in the specification of the present invention are only for the purpose of describing specific embodiments and are not intended to limit the present invention. The term "and / or" used in the present invention includes any and all combinations of one or more of the related listed items.

[0037] In addition, as used in the present invention, the term "or" is an inclusive "or" symbol and is equivalent to the term "and / or", unless the context clearly dictates otherwise. The term "based on" is not exclusive and allows for being based on other factors not described, unless the context clearly dictates otherwise. In addition, throughout the specification, the meanings of "a", "an", and "the" include plural referents. The meaning of "in..." includes "in..." and "on...".

[0038] The aleurone layer of the present invention comprises an aleurone layer and a subaleurone layer.

[0039] The present invention is further described in detail below with reference to specific embodiments.

[0040] Example 1

[0041] Preparation and activity study of purple rice extract.

[0042] 1.1 Experimental Materials and Instruments

[0043] 1.1.1 Materials and reagents

[0044] Table 1 Experimental reagents

[0045]

[0046]

[0047] 1.1.2 Instruments and equipment

[0048] Table 2 Experimental instruments and equipment

[0049]

[0050] 1.2 Preparation and ingredient detection methods and results of purple rice

[0051] 1.2.1 Preparation of Purple Rice Treasures

[0052] A vertical independent rice mill (SATAKE, NDB15A-C) was used to extract rice extract from purple rice (Zhong Zi No. 4):

[0053] Process: remove impurities - hulling - brown rice husk separation - length machine (remove unripe grains) - enter rice mill (sand roller 60#), the weight of each cycle is 350KG, all current values ​​are adjusted according to the slice results (seed coat and endosperm thickness). The product of the fifth milling is extracted as rice treasure.

[0054] First grinding, the current is determined according to the slicing results, breaking the cortex and grinding out the rice husk (current setting 10.7A);

[0055] Second grinding: continue slicing and grinding out the peel (current setting 10.3A);

[0056] The third grinding is to grind out the seed coat (current setting is 10.2A);

[0057] The fourth grinding is to grind out no more than 25% of the aleurone layer (current value 10.1A);

[0058] The fifth grinding is to grind out the remaining endosperm (current value 10.1A) and extract the endosperm.

[0059] Take the product from the fifth grinding and pass it through a 45-mesh sieve to obtain the five-grinding and four-sieve rice treasures.

[0060] 1.2.2 Components of Purple Rice Treasures

[0061] Three batches of purple rice were tested for the following active ingredients:

[0062] 1.2.2.1 Total dietary fiber

[0063] Determination method: National standard GB 5009.88-2014.

[0064] Data (g / 100g): The results showed that the total dietary fiber contents of the three batches of purple rice were 23.31g / 100g, 22.92g / 100g and 23.70g / 100g respectively.

[0065] 1.2.2.2 Soluble dietary fiber

[0066] Determination method: National standard GB 5009.88-2014.

[0067] Data (g / 100g): The results showed that the contents of soluble dietary fiber in the three batches of purple rice were 0.278g / 100g, 0.274g / 100g and 0.273g / 100g respectively.

[0068] 1.2.2.3 Total Vitamin E

[0069] Determination method: National standard GB5009.82-20.16 first method.

[0070] Data (mgα-TE / 100g): The results showed that the total vitamin E contents in the three batches of purple rice were 4.41mgα-TE / 100g, 4.39mgα-TE / 100g and 4.40mgα-TE / 100g respectively.

[0071] 1.2.2.4 Anthocyanins

[0072] Determination method: NY / T2640-2014 (the concentrations of larkspur pigment, cyanidin pigment, geranium pigment, peony pigment and malva pigment are all 0.15 mg / kg, and the concentrations of petunia pigment are 0.5 mg / kg).

[0073] Total amount (mg / kg): The results showed that the anthocyanin contents in the three batches of purple rice were 859.63 mg / kg, 858.91 mg / kg and 864.37 mg / kg respectively.

[0074] 1.3 Analysis of the hypoglycemic and hypolipidemic activities of purple rice in vitro

[0075] 1.3.1 Analysis of the inhibitory effect of purple rice on the activity of enzymes related to sugar metabolism

[0076] α-Amylase inhibitory ability assay.

[0077] Acarbose was used as a positive control. Weigh a certain amount of purple rice sample to prepare a test solution with a suitable concentration gradient, and ultrasonicate for 20 minutes. Take 45μL of the above test solution and 15μL of 0.02mg / mL α-amylase (prepared in 0.1mol / L pH 6.9 PBS) and mix them in a 96-well plate, and incubate at 37°C for 10 minutes. Add 60μL of 0.08% starch solution, react at 37°C for 15 minutes, add 60μL of 1.0mol / L HCl solution to terminate the reaction, and finally add 20μL of 0.01mol / L iodine solution for color development. Measure OD with an enzyme reader 630 The calculation formula is as follows:

[0078]

[0079] Wherein: A1-A4 are sample absorbance, background absorbance (PBS replaces enzyme solution), A negative control absorbance (PBS replaces sample solution), negative control background absorbance (PBS replaces sample solution and enzyme solution).

[0080] The results are as follows Figure 1 As shown by Figure 1 It can be seen that the purple rice product of the present invention has a high α-amylase inhibition rate, indicating that it has good blood sugar lowering activity in vitro.

[0081] 1.3.2 Analysis of the in vitro lipid-lowering activity of purple rice

[0082] Pancreatic lipase inhibition rate determination.

[0083] Pancreatic lipase was prepared into 5mg / mL with distilled water, a certain amount of p-nitrophenyl laurate (pNP laurate) was dissolved in 0.05mol / L sodium acetate aqueous solution containing 1% Triton X-100 to prepare 0.1% (w / v) pNP laurate solution, the prepared solution was placed in hot water to accelerate dissolution, completely mixed and dissolved, and cooled at room temperature for use. Purple rice samples were prepared into solutions with concentrations of 2.5mg / mL, 5mg / mL, 10mg / mL, 20mg / mL, and 40mg / mL with Tris-HCl buffer solution (0.1mol / L, ph8.2). 250μL of reaction substrate, 100μL of sample solution and 200μL of reaction buffer were added to a centrifuge tube, and finally 150μL of lipase solution was added to start the reaction. After being placed at 37℃ for 2h, centrifuged at 10000r / min for 1min, and the absorbance of the supernatant was measured at a wavelength of 420nm. For the blank control, the sample was replaced with a buffer solution, and for the sample control, the lipase solution was replaced with a reaction buffer solution. The lipase inhibition rate was calculated, and the IC50 value was calculated according to the following formula: Pancreatic lipase inhibition rate (%) = (1-(A1-A2) / A0) × 100%; where A1 is the absorbance of the sample supernatant; A2 is the absorbance of the sample control supernatant; A0 is the absorbance of the blank supernatant.

[0084] Depend on Figure 2 It can be seen that the purple rice treasure product of the present invention has a higher pancreatic lipase inhibition rate, indicating that it has good lipid-lowering activity in vitro.

[0085] 1.4 Analysis of the hypoglycemic activity of purple rice in vivo

[0086] 1.4.1 Test materials

[0087] 1.4.1.1 Sample preparation information

[0088] The purple rice treasure of the present invention uses ultrapure water as solvent.

[0089] Positive Control: Pioglitazone hydrochloride tablets (hereinafter referred to as pioglitazone), batch number 2210085203, Jiangsu Deyuan Pharmaceutical Co., Ltd., the solvent is ultrapure water.

[0090] 1.4.1.2 Experimental animals

[0091] Zebrafish were raised in fish farming water at 28°C (water quality: 200 mg of instant sea salt was added to every 1 L of reverse osmosis water, conductivity was 450-550 μS / cm; pH was 6.5-8.5; hardness was 50-100 mg / L CaCO3), the experimental animal use license number is: SYXK (Zhejiang) 2022-0004, and the breeding management complies with the requirements of the international AAALAC certification (certification number: 001458), IACUC ethics review number: IACUC-2024-9178-01.

[0092] 1.4.1.3 Instruments, consumables and reagents

[0093] Dissecting microscope (SZX7, OLYMPUS, Japan); CCD camera (VertA1, Shanghai Tusen Vision Technology Co., Ltd., China); precision electronic balance (CP214, OHAUS, USA); homogenizer (T10, IKA, Germany); blood glucose meter (ACCU-CHEK Performa, Roche Diagnostics (Shanghai) Co., Ltd., China); blood glucose meter test strips (Batch No. 478829, Roche Diagnostics (Shanghai) Co., Ltd., China).

[0094] Egg yolk powder (Batch No. 20230203, Zhejiang Aiger Biotechnology Co., Ltd., China); D-(+)-glucose (Batch No. A2425167, Shanghai Aladdin Biochemical Technology Co., Ltd., China); anhydrous ethanol (Batch No. 20210107, Sinopharm Chemical Reagent Co., Ltd., China).

[0095] 1.4.2 Detection methods

[0096] 1.4.2.1 Maximum detectable concentration (MTC) determination

[0097] Wild-type AB zebrafish at 5 days post-fertilization (dpf) were randomly selected and placed in beakers. Each beaker (experimental group) was treated with 30 zebrafish. The samples were given water-soluble (concentrations are shown in Table 3), and a normal control group and a model control group were set up at the same time, with a volume of 25 mL for each group. Except for the normal control group, each experimental group was given a high-sugar and high-fat diet in water-soluble form to establish a zebrafish hyperglycemia model. After treatment at 28°C for 48 hours, the MTC of the samples on the model zebrafish was measured.

[0098] 1.4.2.2 Evaluation of auxiliary hypoglycemic efficacy

[0099] 5dpf wild-type AB strain zebrafish were randomly selected in beakers, and 30 zebrafish were treated in each beaker (experimental group). The samples were given water-soluble (concentrations are shown in Table 3), and a normal control group and a model control group were set up at the same time, with a capacity of 25mL in each group. Except for the normal control group, each experimental group was given a high-sugar and high-fat diet in water-soluble form to establish a zebrafish hyperglycemia model. After 48 hours of treatment at 28℃, data were collected using a blood glucose meter, and the zebrafish glucose levels were analyzed and statistically analyzed. The statistical analysis results of this indicator were used to evaluate the sample's auxiliary hypoglycemic efficacy. The statistical processing results are expressed as mean±SE. SPSS26.0 software was used for statistical analysis, and p<0.05 indicated that the difference was statistically significant.

[0100] 1.4.3 Test results

[0101] (1)MTC

[0102] Under the experimental conditions, the MTC of the purple rice extract of the present invention for assisting in lowering blood sugar in zebrafish is 2000 μg / mL, as shown in Table 3 for details.

[0103] Table 3 Results of the experimental study on the concentration of purple rice to assist in lowering blood sugar (n=30)

[0104]

[0105]

[0106] (2) Evaluation of auxiliary hypoglycemic efficacy

[0107] The results are shown in Table 4 and Figure 3 shown.

[0108] Table 4 Experimental results of purple rice extract's auxiliary blood sugar lowering effect (n=10)

[0109]

[0110] Compared with the model control group, *p<0.05, ***p<0.001.

[0111] The results showed that compared with the normal control group, the glucose level of zebrafish in the model control group was significantly increased, indicating that the feeding method can successfully establish a hyperglycemic model of zebrafish. Pioglitazone and the purple rice treasure of the present invention can effectively reduce the glucose level of zebrafish in the hyperglycemic model, and the purple rice treasure 1000μg / mL and 2000μg / mL treatment groups of the present invention have lower glucose levels than the pioglitazone treatment group, indicating that the purple rice treasure of the present invention has a good auxiliary blood sugar lowering effect.

[0112] 1.5 Analysis of the in vivo lipid-lowering activity of purple rice

[0113] 1.5.1 Test materials

[0114] 1.5.1.1 Sample preparation information

[0115] The purple rice treasure of the present invention uses ultrapure water as solvent.

[0116] Positive control: Atorvastatin calcium tablets (hereinafter referred to as atorvastatin calcium), batch number 8154200, Pfizer Pharmaceuticals Co., Ltd., the solvent is DMSO.

[0117] 1.5.1.2 Experimental animals

[0118] Zebrafish were raised in fish farming water at 28°C (water quality: 200 mg of instant sea salt was added to every 1 L of reverse osmosis water, conductivity was 450-550 μS / cm; pH was 6.5-8.5; hardness was 50-100 mg / L CaCO3), the experimental animal use license number is: SYXK (Zhejiang) 2022-0004, and the breeding management complies with the requirements of the international AAALAC certification (certification number: 001458), IACUC ethics review number: IACUC-2024-9178-01.

[0119] 1.5.1.3 Instruments, consumables and reagents

[0120] Dissecting microscope (SZX7, OLYMPUS, Japan); CCD camera (VertA1, Shanghai Tusen Vision Technology Co., Ltd., China); precision electronic balance (CP214, OHAUS, USA); electric focus continuous zoom fluorescence microscope (AZ100, Nikon, Japan); microinjection instrument (IM300, Narishige, Japan); needle puller (PC-10, Narishige, Japan); homogenizer (T10, IKA, Germany); 6-well plate (Zhejiang Bellanber Biotechnology Co., Ltd., China).

[0121] Egg yolk powder (Batch No. 20230203, Zhejiang Aiger Biotechnology Co., Ltd., China); D-(+)-glucose (Batch No. A2425167, Shanghai Aladdin Biochemical Technology Co., Ltd., China); dimethyl sulfoxide (DMSO, Batch No. BCCD8942, Sigma, Switzerland); methylcellulose (Batch No. C2004046, Shanghai Aladdin Biochemical Technology Co., Ltd., China); Oil Red O (Oil Red O, Batch No. SHBN4926, Sigma, USA); 1.2-propylene glycol (Batch No. 20211117, Sinopharm Chemical Reagent Co., Ltd., China); cholesterol BODIPy TM 542 / 563C11 (cholesterol probe, lot number 2291600, invitrogen, USA).

[0122] 1.5.2 Detection Method

[0123] 1.5.2.1 Analysis of triglyceride concentration changes in zebrafish

[0124] Randomly select the melanin allele mutant Albino zebrafish 5 days after fertilization (5dpf) in beakers, and treat 30 zebrafish in each beaker (experimental group). The samples were given water-soluble (concentrations are shown in Table 5), and the positive control atorvastatin calcium concentration was 11.6μg / mL. At the same time, a normal control group and a model control group were set up, and the volume of each group was 25mL. Except for the normal control group, each experimental group was given a high-sugar and high-fat diet in water-soluble to establish a zebrafish hyperlipidemia model. After 48h of treatment at 28℃, the samples were collected and stained with oil red. Ten zebrafish were randomly selected from each experimental group and photographed under a dissecting microscope. The NIS-ElementsD3.20 advanced image processing software was used to analyze and collect data. The triglyceride staining intensity of the zebrafish tail blood vessels was analyzed and statistically analyzed. The statistical analysis results of this indicator were used to evaluate the sample's auxiliary lipid-lowering efficacy. The statistical analysis results are expressed as mean±SE. SPSS26.0 software was used for statistical analysis, and p<0.05 indicated that the difference was statistically significant.

[0125] 1.5.2.2 Analysis of cholesterol concentration changes in zebrafish

[0126] 5dpf melanin allele mutant Albino strain zebrafish were randomly selected in beakers, and 30 zebrafish were treated in each beaker (experimental group). The samples were given water-soluble (concentrations are shown in Table 6), and the positive control atorvastatin calcium concentration was 11.6μg / mL. At the same time, a normal control group and a model control group were set up, and the volume of each group was 25mL. Except for the normal control group, each experimental group was given a high-fat and high-fat diet in water-soluble form to establish a zebrafish hyperlipidemia model. After 32h of treatment at 28℃, the cholesterol fluorescent probe was injected. After 16h of treatment at 28℃, 10 zebrafish were randomly selected from each experimental group and placed under a fluorescence microscope for photography. The NIS-ElementsD3.20 advanced image processing software was used to analyze and collect data. The cholesterol fluorescence intensity of the zebrafish tail blood vessels was analyzed and statistically analyzed. The statistical analysis results of this indicator were used to evaluate the sample's auxiliary lipid-lowering efficacy. The statistical analysis results were expressed as mean±SE. SPSS26.0 software was used for statistical analysis, and p<0.05 indicated that the difference was statistically significant.

[0127] 1.5.3 Test results

[0128] (1) Evaluation of the efficacy of assisting in lowering blood lipids (triglycerides)

[0129] The experimental results of the purple rice extract of the present invention on reducing triglycerides are shown in Table 5. Figure 4 and Figure 5 shown.

[0130] Table 5 Experimental results of purple rice extract's auxiliary blood lipid lowering effect (triglyceride) (n=10)

[0131]

[0132]

[0133] Compared with the model control group, **p<0.01, ***p<0.001.

[0134] Compared with the normal control group, the triglyceride level of zebrafish in the model control group was significantly increased, indicating that the breeding method can successfully establish a zebrafish hyperlipidemia model. Treatment with atorvastatin calcium and the purple rice extract of the present invention can effectively reduce the triglyceride staining intensity of the zebrafish tail blood vessels, indicating that the purple rice extract of the present invention has a significant auxiliary triglyceride-lowering effect.

[0135] (2) Evaluation of the efficacy of assisting in lowering blood lipids (cholesterol)

[0136] The experimental results of the purple rice treasure of the present invention on reducing cholesterol are shown in Table 6. Figure 6 and Figure 7 shown.

[0137] Table 6 Experimental results of purple rice extract's auxiliary blood lipid lowering effect (cholesterol) (n=10)

[0138]

[0139] Compared with the model control group, ***p<0.001.

[0140] Compared with the normal control group, the cholesterol level of zebrafish in the model control group was significantly increased, indicating that the breeding method can successfully establish a zebrafish hyperlipidemia model. Treatment with atorvastatin calcium and the purple rice extract of the present invention can effectively reduce the cholesterol fluorescence intensity of the zebrafish tail blood vessels, indicating that the purple rice extract of the present invention has a good cholesterol-lowering effect.

[0141] The above results show that the purple rice extract of the present invention can effectively reduce the triglyceride and cholesterol levels of the hyperlipidemia model zebrafish, and has a good lipid-lowering activity in the zebrafish.

[0142] 1.6 Analysis of the laxative activity of purple rice

[0143] 1.6.1 Testing materials

[0144] 1.6.1.1 Sample preparation information

[0145] The purple rice treasure of the present invention uses ultrapure water as solvent.

[0146] Positive Control: Domperidone tablets (hereinafter referred to as domperidone), white tablets, batch number NBJ6613, Xi'an Janssen Pharmaceutical Co., Ltd., solvent is DMSO.

[0147] 1.6.1.2 Experimental animals

[0148] Zebrafish were raised in fish farming water at 28°C (water quality: 200 mg of instant sea salt was added to every 1 L of reverse osmosis water, conductivity was 450-550 μS / cm; pH was 6.5-8.5; hardness was 50-100 mg / L CaCO3), the experimental animal use license number is: SYXK (Zhejiang) 2022-0004, and the breeding management complies with the requirements of the international AAALAC certification (certification number: 001458), IACUC ethics review number: IACUC-2024-9178-01.

[0149] 1.6.1.3 Instruments, consumables and reagents

[0150] Dissecting microscope (SZX7, OLYMPUS, Japan); CCD camera (VertA1, Shanghai Tusen Vision Technology Co., Ltd., China); electric focus continuous zoom fluorescence microscope (AZ100, Nikon, Japan); precision electronic balance (CP214, OHAUS, USA); 6-well plate (Zhejiang Bellambo Biotechnology Co., Ltd., China); 150mm*25mm culture dish (OrangeScientific, Belgium).

[0151] Methylcellulose (Batch No. C2004046, Shanghai Aladdin Biochemical Technology Co., Ltd., China); dimethyl sulfoxide (DMSO, Batch No. I2229063, Shanghai Aladdin Biochemical Technology Co., Ltd., China); Nile red (Batch No. SLBP9326V, Sigma, India).

[0152] 1.6.2 Experimental methods

[0153] 5dpf wild-type AB strain zebrafish were randomly selected and 10.0ng / mL Nile red was administered in water as a fluorescent indicator of intestinal contents. The zebrafish intestinal peristalsis model was established by intestinal labeling with Nile red. The anatomical structure and tissue cell morphology of the zebrafish digestive tract are similar to those of the human digestive tract, with an epithelial layer, a lamina propria, and a muscle layer. When zebrafish develop to 5dpf, spontaneous rhythmic muscle contraction activities appear in their digestive tract. After feeding a specific in vivo fluorescent marker dye Nile red, the amount of Nile red (fluorescence intensity) in the zebrafish intestine can be clearly observed. If the sample has a laxative effect, the intestinal peristalsis will be accelerated, the residual Nile red in the intestine will be reduced, and the fluorescence intensity will be significantly weakened.

[0154] After 16 hours of feeding, Nile red was washed off and zebrafish were randomly assigned to 6-well plates, with 30 zebrafish treated in each well (experimental group). The samples were given water-soluble (concentrations are shown in Table 7), the positive control was domperidone at a concentration of 30.0 μg / mL, and a normal control group was set up at the same time, with a capacity of 3 mL per well. After 1 day of treatment at 28°C, 10 zebrafish were randomly selected from each group and photographed under a fluorescence microscope and saved. The data were analyzed and collected using NIS-E1ements D 3.20 advanced image processing software, and the fluorescence intensity of the zebrafish intestine was analyzed. The statistical analysis results of this indicator were used to evaluate the laxative effect of the sample. The statistical analysis results were expressed as mean ± SE. SPSS26.0 software was used for statistical analysis, and p < 0.05 indicated that the difference was statistically significant.

[0155] 1.6.3 Experimental Results

[0156] The experimental results are shown in Table 7. Figure 8 and Fig. 9 .

[0157] Table 7 Results of the experimental study on the effect of moistening the intestine and relieving constipation of samples (n=10)

[0158]

[0159] Compared with the normal control group, **p<0.01, ***p<0.001.

[0160] Compared with the normal control group, domperidone and the purple rice treasure of the present invention can effectively reduce the intestinal fluorescence intensity, and the effect of domperidone on reducing the intestinal fluorescence intensity of the purple rice treasure at concentrations of 1000 μg / mL and 2000 μg / mL is better than that of domperidone, indicating that the purple rice treasure of the present invention can effectively promote the intestinal peristalsis of zebrafish and has a good effect of moisturizing the intestine and relieving constipation.

[0161] In summary, by combining purple rice (structure such as Fig.10 The purple rice extract of the present invention is prepared by grinding the raw material of the present invention (as shown in the figure) in a graded manner, and then the fifth milled product containing most of the aleurone layer is passed through a suitable mesh sieve to obtain the purple rice extract of the present invention, which contains a variety of active substances, can effectively reduce blood sugar and blood lipids, promote intestinal peristalsis, and moisturize the intestines and relieve constipation. Therefore, the purple rice extract of the present invention can be used to prepare biological preparations for lowering blood sugar, lowering blood lipids and promoting intestinal peristalsis, including medicines, foods and health products, etc., which greatly improves the utilization value of purple rice resources.

[0162] The above-mentioned embodiments only express several implementation methods of the present invention, and the descriptions thereof are relatively specific and detailed, but they cannot be understood as limiting the scope of the invention patent. It should be pointed out that, for ordinary technicians in this field, several variations and improvements can be made without departing from the concept of the present invention, and these all belong to the protection scope of the present invention. Therefore, the protection scope of the patent of the present invention shall be subject to the attached claims.

Claims

1. A method for preparing purple rice treasure, characterized in that: The method of extracting rice extract from purple rice using a rice mill includes the following steps: (1) First grinding: grinding out the rice husks; (2) Second grinding: grinding out the peel; (3) Third grinding: grinding out the seed coat; (4) Fourth grinding: grinding out no more than 25% of the aleurone layer; (5) Fifth grinding: Grind out the remaining aleurone layer, collect the ground material, and pass it through a 30-45 mesh sieve to obtain the final product.

2. The preparation method according to claim 1, characterized in that The milled material is collected and passed through a 40-45 mesh sieve; preferably, the milled material is collected and passed through a 45 mesh sieve.

3. The preparation method according to claim 1, characterized in that: The rice mill uses 40#-60# sand rollers; Preferably, the rice mill uses a 60# sand roller; the current of the first mill is 10.7±0.2A; and / or the current of the second mill is 10.3±0.2A; and / or the current of the third mill is 10.2±0.2A; and / or the current of the fourth mill is 10.1±0.2A; and / or the current of the fifth mill is 10.1±0.2A.

4. The preparation method according to claim 1, characterized in that: The purple rice is Zhongzi No.

4.

5. The purple rice treasure obtained by the preparation method according to any one of claims 1 to 4.

6. Use of the purple rice extract as claimed in claim 5 in the preparation of a biological agent for lowering blood lipids.

7. Use of the purple rice extract as claimed in claim 5 in the preparation of a biological preparation for promoting intestinal peristalsis.

8. Use of the purple rice extract as claimed in claim 5 in preparing a hypoglycemic biological preparation.

9. The use according to any one of claims 6 to 8, characterized in that: The biological preparation is a medicine, a health product or a food.

10. A biological agent for lowering blood sugar, lowering blood lipids or promoting intestinal motility, characterized in that: It comprises active ingredients and excipients, wherein the active ingredients include the purple rice treasure as described in claim 5; and the excipients are pharmaceutically acceptable carriers, health care product acceptable carriers or food acceptable carriers.